These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


368 related items for PubMed ID: 8873344

  • 1. Hemostasis, platelet function and serotonin in acute and chronic renal failure.
    Malyszko J, Malyszko JS, Pawlak D, Pawlak K, Buczko W, Mysliwiec M.
    Thromb Res; 1996 Sep 01; 83(5):351-61. PubMed ID: 8873344
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A study of platelet functions, some hemostatic and fibrinolytic parameters in relation to serotonin in hemodialyzed patients under erythropoietin therapy.
    Malyszko J, Malyszko JS, Borawski J, Rydzewski A, Kalinowski M, Azzadin A, Mysliwiec M, Buczko W.
    Thromb Res; 1995 Jan 15; 77(2):133-43. PubMed ID: 7740505
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A comprehensive study on hemostasis in CAPD patients treated with erythropoietin.
    Malyszko J, Suchowierska E, Malyszko JS, Mysliwiec M.
    Perit Dial Int; 2002 Jan 15; 22(5):582-92. PubMed ID: 12455569
    [Abstract] [Full Text] [Related]

  • 7. The coagulation/fibrinolysis balance in systemic sclerosis: evidence for a haematological stress syndrome.
    Ames PR, Lupoli S, Alves J, Atsumi T, Edwards C, Iannaccone L, Khamashta MA, Hughes GR, Brancaccio V.
    Br J Rheumatol; 1997 Oct 15; 36(10):1045-50. PubMed ID: 9374919
    [Abstract] [Full Text] [Related]

  • 8. Plasma levels of total plasminogen activator inhibitor-I (PAI-I) and tPA/PAI-1 complex in patients with disseminated intravascular coagulation and thrombotic thrombocytopenic purpura.
    Watanabe R, Wada H, Miura Y, Murata Y, Watanabe Y, Sakakura M, Okugawa Y, Nakasaki T, Mori Y, Nishikawa M, Gabazza EC, Shiku H, Nobori T.
    Clin Appl Thromb Hemost; 2001 Jul 15; 7(3):229-33. PubMed ID: 11441985
    [Abstract] [Full Text] [Related]

  • 9. Coagulation-fibrinolysis system in poststroke patients receiving antiplatelet medication.
    Tohgi H, Takahashi H, Chiba K, Tamura K.
    Stroke; 1993 Jun 15; 24(6):801-4. PubMed ID: 8506551
    [Abstract] [Full Text] [Related]

  • 10. Lipid-related hemostatic abnormalities in the elderly: imbalance between coagulation and fibrinolysis.
    Kario K, Matsuo T.
    Atherosclerosis; 1993 Nov 15; 103(2):131-8. PubMed ID: 8292090
    [Abstract] [Full Text] [Related]

  • 11. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC, Middeldorp S, Tekelenburg W, van den Ende AE, Tans G, Prins MH, Rosing J, Büller HR, Bouma BN.
    Thromb Haemost; 2000 Jul 15; 84(1):9-14. PubMed ID: 10928462
    [Abstract] [Full Text] [Related]

  • 12. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
    Van Geet C, Proesmans W, Arnout J, Vermylen J, Declerck PJ.
    Kidney Int; 1998 Oct 15; 54(4):1324-30. PubMed ID: 9767551
    [Abstract] [Full Text] [Related]

  • 13. Hemostatic disorder of uremia: the platelet defect, main determinant of the prolonged bleeding time, is correlated with indices of activation of coagulation and fibrinolysis.
    Mezzano D, Tagle R, Panes O, Pérez M, Downey P, Muñoz B, Aranda E, Barja P, Thambo S, González F, Mezzano S, Pereira J.
    Thromb Haemost; 1996 Sep 15; 76(3):312-21. PubMed ID: 8883263
    [Abstract] [Full Text] [Related]

  • 14. Blood coagulation, fibrinolytic, and inhibitory proteins in end-stage renal disease: effect of hemodialysis.
    Vaziri ND, Gonzales EC, Wang J, Said S.
    Am J Kidney Dis; 1994 Jun 15; 23(6):828-35. PubMed ID: 8203365
    [Abstract] [Full Text] [Related]

  • 15. Physical exertion induces thrombin formation and fibrin degradation in patients with peripheral atherosclerosis.
    Mustonen P, Lepäntalo M, Lassila R.
    Arterioscler Thromb Vasc Biol; 1998 Feb 15; 18(2):244-9. PubMed ID: 9484989
    [Abstract] [Full Text] [Related]

  • 16. Perhaps it's not the platelet: Ristocetin uncovers the potential role of von Willebrand factor in impaired platelet aggregation following traumatic brain injury.
    Kornblith LZ, Robles AJ, Conroy AS, Hendrickson CM, Calfee CS, Fields AT, Callcut RA, Cohen MJ.
    J Trauma Acute Care Surg; 2018 Nov 15; 85(5):873-880. PubMed ID: 29985231
    [Abstract] [Full Text] [Related]

  • 17. Endothelial cell injury markers in chronic renal failure on conservative treatment and continuous ambulatory peritoneal dialysis.
    Małyszko J, Małyszko JS, Myśliwiec M.
    Kidney Blood Press Res; 2004 Nov 15; 27(2):71-7. PubMed ID: 14691349
    [Abstract] [Full Text] [Related]

  • 18. Absence of paradoxical thrombin activation by fibrin-specific thrombolytics in acute myocardial infarction: comparison of single-bolus tenecteplase and front-loaded alteplase.
    Szabo S, Letsch R, Ehlers R, Walter T, Kazmaier S, Helber U, Hoffmeister HM.
    Thromb Res; 2002 Apr 15; 106(2):113-9. PubMed ID: 12182909
    [Abstract] [Full Text] [Related]

  • 19. Increased levels of vascular endothelial cell markers in thrombotic thrombocytopenic purpura.
    Wada H, Kaneko T, Ohiwa M, Tanigawa M, Hayashi T, Tamaki S, Minami N, Deguchi K, Suzuki K, Nakano T.
    Am J Hematol; 1993 Oct 15; 44(2):101-5. PubMed ID: 8266913
    [Abstract] [Full Text] [Related]

  • 20. The fibrinolytic effects of intermittent pneumatic compression: mechanism of enhanced fibrinolysis.
    Comerota AJ, Chouhan V, Harada RN, Sun L, Hosking J, Veermansunemi R, Comerota AJ, Schlappy D, Rao AK.
    Ann Surg; 1997 Sep 15; 226(3):306-13; discussion 313-4. PubMed ID: 9339937
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.